Research Analysts’ New Coverage for October 20th (ADRX, ASYS, BAX, BDX, CLYM, CON, ENSC, EVMN, GEHC, HUBB)

Research Analysts’ new coverage for Tuesday, October 20th:

JPMorgan Chase & Co. began coverage on shares of ADARx Pharmaceuticals (NASDAQ:ADRX). The firm issued an overweight rating and a $38.00 target price on the stock.

Lake Street Capital began coverage on shares of Amtech Systems (NASDAQ:ASYS). The firm issued a buy rating and a $22.00 target price on the stock.

Wolfe Research started coverage on shares of Baxter International (NYSE:BAX). Wolfe Research issued a peer perform rating on the stock.

Wolfe Research initiated coverage on shares of Becton, Dickinson and Company (NYSE:BDX). They issued an outperform rating on the stock.

Deutsche Bank Aktiengesellschaft initiated coverage on shares of Climb Bio (NASDAQ:CLYM). Deutsche Bank Aktiengesellschaft issued a buy rating and a $28.00 price target on the stock.

Stephens assumed coverage on shares of Concentra Group Holdings Parent (NYSE:CON). The firm issued an overweight rating and a $45.00 price target on the stock.

Cantor Fitzgerald initiated coverage on shares of Ensysce Biosciences (NASDAQ:ENSC). The firm issued an overweight rating and a $2.00 target price on the stock.

Morgan Stanley started coverage on shares of Evommune (NYSE:EVMN). They issued an overweight rating and a $26.00 price target on the stock.

Wolfe Research assumed coverage on shares of GE HealthCare Technologies (NASDAQ:GEHC). Wolfe Research issued a peer perform rating on the stock.

JPMorgan Chase & Co. initiated coverage on shares of Hubbell (NYSE:HUBB). JPMorgan Chase & Co. issued a neutral rating and a $485.00 price target on the stock.

Morgan Stanley started coverage on shares of Incyte (NASDAQ:INCY). They issued an equal weight rating and a $119.00 price target on the stock.

Evercore Inc began coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS). Evercore Inc issued an outperform rating and a $34.00 target price on the stock.

Leerink Partners began coverage on shares of Novogen (NASDAQ:KZIA). They issued an outperform rating and a $30.00 target price on the stock.

Morgan Stanley initiated coverage on shares of Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT). Morgan Stanley issued an equal weight rating and a $26.00 price target on the stock.

William Blair assumed coverage on shares of Midera Food Processing (NASDAQ:MFP). They issued an outperform rating on the stock.

Cantor Fitzgerald started coverage on shares of Modine Manufacturing (NYSE:MOD). Cantor Fitzgerald issued an overweight rating and a $275.00 target price on the stock.

JPMorgan Chase & Co. started coverage on shares of Mplx (NYSE:MPLX). They issued a neutral rating and a $62.00 price target on the stock.

JPMorgan Chase & Co. initiated coverage on shares of nVent Electric (NYSE:NVT). JPMorgan Chase & Co. issued an overweight rating and a $167.00 price target on the stock.

Mizuho initiated coverage on shares of Restaurant Brands International (NYSE:QSR) (TSE:QSR). They issued an outperform rating and a $85.00 target price on the stock.

Rosenblatt Securities assumed coverage on shares of SiTime (NASDAQ:SITM). They issued a buy rating and a $750.00 price target on the stock.

JPMorgan Chase & Co. started coverage on shares of Sunoco (NYSE:SUN). They issued an overweight rating and a $87.00 target price on the stock.

Jefferies Financial Group Inc. started coverage on shares of Thomson Reuters (NASDAQ:TRI). The firm issued a buy rating and a $130.00 price target on the stock.

Chardan Capital started coverage on shares of Tvardi Therapeutics (NASDAQ:TVRD). Chardan Capital issued a buy rating on the stock.

JPMorgan Chase & Co. assumed coverage on shares of Western Midstream Partners (NYSE:WES). JPMorgan Chase & Co. issued a neutral rating and a $50.00 price target on the stock.

Morgan Stanley began coverage on shares of Zenas BioPharma (NASDAQ:ZBIO). They issued an equal weight rating and a $32.00 target price on the stock.